LGALS3 and COVID-19: Another study reported that COVID-19 patients with serum levels of Gal-3 more than 35.3 ng/ml were associated with higher mortality, ICU hospitalization, and severe acute respiratory syndrome, implying its importance as a prognostic biomarker for mortality and disease severity (132).